Rash, drug hypersensitivity, and autoimmunity in a 20-year-old woman

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 2, 2005, Pages 111-114

  Kaplan, Jennifer ^a,b   Anand, Prachi ^a,b   Frieri, Marianne ^a,b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CELECOXIB; HYDROXYCHLOROQUINE SULFATE; PREDNISONE; WARFARIN;

ADULT; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; AUTOIMMUNITY; CASE REPORT; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; LABORATORY TEST; LEG EDEMA; MYALGIA; PHARYNGITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

EID: 23844548275     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61199-4     Document Type: Article

References (23)

1. de Shazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA. 1997;278:1895-1906.
2. Anderson JA. Drug allergy. In: Kaliner M, ed. Current Review of Allergic Diseases. Philadelphia, PA: Blackwell Science; 1999:192-202.
3. Bernstein I, Gruchalla R, Lee R, Nicklas R, Dykewicz M. Disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol. 1999;83:665-700.
4. Gruchalla RS. Drug metabolism, danger signal and drug-induced hypersensitivity. J Allergy Clin Immunol. 2001;108: 475-488.
5. Brugnolo F, Annunziato F, Sampognaro S, et al. Highly Th2-skewed cytokine profile of beta-lactam specific T cells from nonatopic subjects with adverse drug reactions. J Immunol. 1999;163:1053-1059.
6. Reilly T, Lash L, Doll M, et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide induced cutaneous drug reactions. J Invest Dermatol. 2000;114: 1164-1173.
7. Gruchalla RS. Management of adverse drug reactions. In: Update in Allergy Immunology. East Meadow, NY: Nassau University Medical Center; October 2002.
8. Mongey AB, Hess EV. Drug and environmental lupus: clinical manifestations and differences. In: Lahita R, ed. Systemic Lupus Erythematosus. 3rd ed. San Diego, CA: Academic Press; 1998: 929-943.
9. Sontheimer RD. Systemic lupus erythematosus and the skin. In: Lahita R, ed. Systemic Lupus Erythematosus. 3rd ed. San Diego, CA: Academic Press; 1998:631-656.
10. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol. 1991;49:193-280.
11. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med. 1990;112:682-698.
12. McHugh NJ, Moye DAH, James IE, Sampson M, Maddison PJ. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. Ann Rheum Dis. 1991;50:548-552.
13. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am. 1993; 19:235-247.
14. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990; 87:4120-4124.
15. Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin North Am. 1990;16:617-639.
16. Liang MH, Partridge AJ, Daltroy LH, et al. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum. 1991;34:1187-1196.
17. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64.
18. Mansur A, Frieri M. Behcet's disease vs Behcet's syndrome with some criteria for systemic lupus erythematosus. Pediatr Allergy Asthma Immunol. 1998;12:53-59.
19. Klippel JH. Systemic lupus erythematosus-treatment. In: Primer on the Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 1997:258-262.
20. Mills JA. Systemic lupus erythematosus. N Engl J Med. 1994; 330:1871-1879.
21. Pisetsky DS. Systemic lupus erythematosus: epidemiology, pathology, and pathogenesis. In: Primer on Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 1997:246-251
22. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
23. Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 2003;24:421-429.